An Investigation to Determine an Optimum Protective Garment Material in Nuclear Medicine

Parvaresh, R; Haghparast, A; Khoshgard, K; Jalili, M; Eivazi, M T; Ghorbani, M

doi:10.31661/jbpe.v8i4Dec.804

An Investigation to Determine an Optimum Protective Garment Material in Nuclear Medicine

Document Type : Original Research

Authors

R Parvaresh ¹

A Haghparast ²

K Khoshgard ²

M Jalili ³

M T Eivazi ²

M Ghorbani ⁴

¹ Medical Physics Department, Students Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran

² Medical Physics Department, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran

³ Nuclear Medicine Department, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran

⁴ Biomedical Engineering and Medical Physics Department, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

https://doi.org/10.31661/jbpe.v8i4Dec.804

Abstract

Aim: The aim of this study is to find an optimum material to protect garment for protection against 99Tcm radionuclide.
Materials and Methods: Monte Carlo simulation code was applied to investigate radiation attenuation of 13 shielding materials including: Ba, gray Sn, white Sn, Sb, Bi, Bi2O3, BaSO4, Sn/W, Sb/W, Pb and W with thicknesses of 0.5 and 1 mm to determine an optimum protective garment material in nuclear medicine against 99Tcm. Furthermore, the dose enhancement on the staff body was investigated for shielding materials such as tungsten and lead.
Results: The findings of the simulations show that the maximum and minimum attenuation obtained with thicknesses of 1 mm W and 1 mm BaSO4 were 96.46% and 14.2%, respectively. The results also demonstrate that tungsten does not cause any dose enhancement on staff body but this is not true for lead. Tungsten provides the highest radiation attenuation without dose enhancement on the body of staff.
Conclusion: Among materials evaluated, tungsten is the optimum material and it can be applied for the design of protective garment for nuclear medicine staff against 99Tcm.

Keywords

Nuclear Medicine

Monte Carlo Simulation

99Tcm

Protective Garment

Hosseinimehr SJ. Potential utility of radioprotective agents in the practice of nuclear medicine. Cancer Biother Radiopharm. 2009;24:723-31. doi: 10.1089/cbr.2009.0635. PubMed PMID: 20025553.
White S, Gingold E, Yester M. The effectiveness of lead aprons for radiation protection in nuclear medicine. Med Phys. 2001;28:1277-8.
Steyn PF, Uhrig J. The role of protective lead clothing in reducing radiation exposure rates to personnel during equine bone scintigraphy. Vet Radiol Ultrasound. 2005;46:529-32. PubMed PMID: 16396274.
Mattsson S, Hoeschen C. The importance of radiation protection in nuclear medicine. In: Mattsson S, Hoeschen C, editors. Radiation protection in nuclear medicine . 1st ed. Malmo: Springer-Verlag Berlin Heidelberg; 2013.
Warren-Forward H, Cardew P, Smith B, Clack L, McWhirter K, Johnson S, et al. A comparison of dose savings of lead and lightweight aprons for shielding of 99m-Technetium radiation. Radiat Prot Dosimetry. 2007;124:89-96. doi: 10.1093/rpd/ncm176. PubMed PMID: 17525062.
Young AM. Dose rates in nuclear medicine and the effectiveness of lead aprons: updating the department’s knowledge on old and new procedures. Nucl Med Commun. 2013;34:254-64. doi: 10.1097/MNM.0b013e32835c91d5. PubMed PMID: 23353888.
Ahmed S, Zimmer A, McDonald N, Spies S. The effectiveness of lead aprons in reducing radiation exposures from specific radionuclides. J Nucl Med. 2007;48:470P.
Fog LS, Collins P. Monte Carlo simulation of the dose to nuclear medicine staff wearing protective garments. Australas Phys Eng Sci Med. 2008;31:307-16. PubMed PMID: 19239057.
Finnerty M, Brennan PC. Protective aprons in imaging departments: manufacturer stated lead equivalence values require validation. Eur Radiol. 2005;15:1477-84. doi: 10.1007/s00330-004-2571-2. PubMed PMID: 15789212.
Deb P, Jamison R, Mong L, U P. An evaluation of the shielding effectiveness of lead aprons used in clinics for protection against ionising radiation from novel radioisotopes. Radiat Prot Dosimetry. 2015;165:443-7. doi: 10.1093/rpd/ncv065. PubMed PMID: 25848112.
Twaite K, Borham P, Southeel A. The use of lightweight aprons to significantly reduce radiation exposure in nuclear medicine. April 27, 2007. Perth: 36th Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine.
Regulla DF, Hieber LB, Seidenbusch M. Physical and biological interface dose effects in tissue due to X-ray-induced release of secondary radiation from metallic gold surfaces. Radiat Res. 1998;150:92-100. PubMed PMID: 9650606.
Cheung JY, Tang FH. The calculation of dose enhancement close to platinum implants for skull radiography. Health Phys. 2007;93:267-72. doi: 10.1097/01.HP.0000264450.81683.51. PubMed PMID: 17846522.
Vucina J, Nikolic N, Orlic M, editors. Radioisotopes for diagnostics-Status and prospects. September 27-30, 2004. Belgrade: Fifth Yugoslav nuclear society conference (YUNSC); 2004.
Saleh TB. Technetum-99m Radiopharmaceuticals. In: Magdy M Khalil, editor. Basic sciences of nuclear medicine. New York: Springer Science & Business Media; 2010.
Shultis JK, Faw RE. An MCNP primer. Manhattan: Kansas State University; 2011.
Mi Tech Tungsten Metals LLC [internet] . Dose limits for radiation workers. [Last Accessed on 2016 Nov] Available from:[http://www.nrc.gov/about-nrc/radiation/health-effect/info.html. ]
Mi Tech Tungsten Metals LLC [internet]. High density tungsten alloy applications. [Last accessed on 2016 Sept]. Available from: http://www.mi-techmetals.com/tungsten-alloys/hd-tungsten-alloy-applications
Lenntech [internet]. Chemical properties of lead-Health effects of lead-Environmental effects of lead. [Last accessed on 2016 Nov]. Available from: http://www.lenntech.com/periodic/elements/pb.html.